Rifaximin Demonstrates Highly Statistically Significant Results In Prevention Of Hepatic Encephalopathy In Pivotal Phase 3 Study - Tidingo.com

Rifaximin Demonstrates Highly Statistically Significant Results In Prevention Of Hepatic Encephalopathy In Pivotal Phase 3 Study

Link:

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the successful completion and outcome of its pivotal Phase 3 trial to evaluate the efficacy, safety and tolerability of rifaximin in preventing hepatic encephalopathy, or HE.

Rifaximin Demonstrates Highly Statistically Significant Results In Prevention Of Hepatic Encephalopathy In Pivotal Phase 3 Study - témata

Demonstrates, Highly, Statistically, Significant, Results, Prevention, Hepatic, Encephalopathy, Pivotal, Phase, Study, Rifaximin Demonstrates Highly Statistically Significant Results, Hepatic Encephalopathy, Pivotal Phase, Pharmaceuticals, Ltd, (NASDAQ:SLXP), Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP), Rifaximin Demonstrates Highly Statistically Significant Results In Prevention Of Hepatic Encephalopathy In Pivotal Phase 3 Study,

Podobné zprávy

RSS sources

Your own sources

Your own RSS you can add after registration

Public sources


Create an account Password
© 2005-2008  
RSS Sources list
Wallpapers | RSS čtečka | Webové stránky | Sportovní hry | Webhry | Texty písní | Závody | Dětské hry | Repliky zbraní | TIXIK.com | Mapy | Pattaya Hotels | Honeymoon Planning | Torent download | Parfémy | Sydney | Москва | Bitky.net | Pocitacove-hry.net | Obrazky-tapety.com | Muži | Celebrity | České celebrity | Bulvár | Soutěže o ceny | Finance | Cestování | MP3 | Kalendář online, svátky | SEO | Svářečky CO2 | Chovatelské potřeby | New York | Knihy levně |
Loading messages